Trump’s DOJ Defends Drug Price Program in Third Circuit Brief

The Trump administration is moving forward with the defense of a Biden-era plan that allows Medicare to negotiate drug prices against Novartis AG’s appeal at the Third Circuit.

The US Department of Justice pushed back on Novartis’s challenge that the Medicare Drug Price Negotiation program violates various amendments of the US Constitution in a brief filed Wednesday in the US Court of Appeals for the Third Circuit. There was uncertainty whether President Donald Trump would move forward with the program in its current form after drugmakers said they planned to ask the president to pause it.

The Pharmaceutical Research ...